Insmed Incorporated Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Insmed Incorporated income statement - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue0.360.310.250.190.160.140.01
Cost of Revenue0.090.070.060.040.040.020.00
Gross Profit0.280.240.190.140.120.110.01
Operating Expenses
Research & Development0.600.570.400.270.180.130.15
Selling, General & Administrative0.460.340.270.230.200.210.17
Operating Expenses1.060.920.670.510.390.350.31
Operating Income-0.79-0.68-0.48-0.38-0.27-0.24-0.31
Other Income/Expense
Interest Income0.000.000.010.000.000.000.00
Interest Expense0.080.08-0.030.04-0.030.000.02
Other Income/Expense-0.040.02-0.010.030.00-0.010.01
Income
Income Before Tax-0.91-0.75-0.48-0.44-0.29-0.25-0.32
Income Tax Expense0.000.000.000.000.000.000.00
Net Income-0.91-0.75-0.48-0.43-0.29-0.25-0.32
Net Income - Continuous Operations-0.91-0.75-0.48-0.430.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-0.82-0.66-0.47-0.38-0.25-0.20-0.30
EBIT-0.83-0.67-0.48-0.40-0.27-0.23-0.30
Depreciation & Amortization0.010.010.010.010.020.000.00
Earnings Per Share
Basic EPS-6.00-5.00-4.00-4.00-3.00-3.00-4.00
Diluted EPS-6.00-5.00-4.00-4.00-3.00-3.00-4.00
Basic Shares Outstanding0.160.140.120.110.100.080.08
Diluted Shares Outstanding0.160.140.120.110.100.080.08